All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Update information: August 2016: NICE removed the following research recommendations: - What is the clinical and cost effectiveness of CBT for the treatment of moderate and severe anxiety disorders in autistic adults? - What is the clinical and cost effectiveness of selective serotonin reuptake inhibitors (SSRIs) for the treatment of moderate and severe depression in autistic adults? Minor changes since publication June 2021: NICE changed 'people with autism' to 'autistic people', 'challenging behaviour' to 'behaviour that challenges', and 'symptoms' to 'features' to align with current terminology. July 2020: NICE linked to the NICE guideline on supporting adult carers in recommendations 1.1.17, 1.7.1 and 1.7.2. We incorporated footnotes into the recommendations. For the current recommendations, see www.nice.org.uk/guidance/CG142/chapter/recommendations.
Excerpt
Autism is a lifelong condition with particular issues for adults, which are addressed by this NICE guideline. While some people are diagnosed in childhood, a large proportion of adults with autism find obtaining a diagnosis in adulthood difficult or impossible. Under-recognition of autism in adults can lead to inadequate care, masking of coexisting mental and physical health problems, and to social and economic exclusion. This guideline aims to address these widespread problems and increase the uptake of interventions by adults with autism to enable them to live more independent lives.
This guideline reviews the evidence for support and interventions for adults with autism across the care pathway, from identification, assessment and diagnosis, to organisation, delivery and settings for care, through to psychosocial and biomedical interventions for autism, challenging behaviour and coexisting mental health problems. The guideline also contains a chapter on the experience of care for adults with autism, and their families and carers, which provides a context for the evidence reviews that follow.
Contents
- GUIDELINE DEVELOPMENT GROUP MEMBERS
- ACKNOWLEDGEMENTS
- 1. PREFACE
- 2. INTRODUCTION TO AUTISM IN ADULTS
- 3. METHODS USED TO DEVELOP THIS GUIDELINE
- 4. EXPERIENCE OF CARE
- 5. CASE IDENTIFICATION, ASSESSMENT AND DIAGNOSIS
- 6. PRINCIPLES AND PRACTICE FOR THE EFFECTIVE ORGANISATION AND DELIVERY OF CARE
- 7. PSYCHOSOCIAL INTERVENTIONS
- 7.1. INTRODUCTION
- 7.2. CLINICAL EVIDENCE REVIEW OF PSYCHOSOCIAL INTERVENTIONS
- 7.3. BEHAVIOURAL THERAPIES AIMED AT COMMUNICATION
- 7.4. FACILITATED COMMUNICATION
- 7.5. BEHAVIOURAL THERAPIES AIMED AT BEHAVIOUR MANAGEMENT
- 7.6. COGNITIVE BEHAVIOURAL THERAPIES
- 7.7. LEISURE PROGRAMMES
- 7.8. SOCIAL LEARNING INTERVENTIONS
- 7.9. SUPPORTED EMPLOYMENT PROGRAMMES
- 7.10. SUPPORT FOR FAMILIES, PARTNERS AND CARERS
- 8. BIOMEDICAL INTERVENTIONS
- 8.1. INTRODUCTION
- 8.2. ANTIPSYCHOTICS FOR BEHAVIOUR MANAGEMENT
- 8.3. ANTICONVULSANTS FOR BEHAVIOUR MANAGEMENT
- 8.4. DRUGS AFFECTING COGNITION FOR BEHAVIOUR MANAGEMENT
- 8.5. HORMONAL INTERVENTIONS: ADRENOCORTICOTROPHIC HORMONE FOR BEHAVIOUR MANAGEMENT
- 8.6. HORMONAL INTERVENTIONS: SECRETIN FOR AUTISTIC BEHAVIOURS
- 8.7. HORMONAL INTERVENTIONS: OXYTOCIN FOR CORE SYMPTOMS OF AUTISM
- 8.8. HORMONAL INTERVENTIONS: MELATONIN FOR COEXISTING CONDITIONS
- 8.9. STIMULANTS FOR COEXISTING CONDITIONS
- 8.10. ANXIOLYTICS FOR COEXISTING CONDITIONS
- 8.11. ANTIDEPRESSANTS FOR AUTISTIC BEHAVIOURS
- 8.12. EXCLUSION DIETS, VITAMINS, MINERALS AND SUPPLEMENTS FOR AUTISTIC BEHAVIOURS
- 8.13. CHELATION FOR AUTISTIC BEHAVIOURS
- 8.14. TESTOSTERONE REGULATION FOR AUTISTIC BEHAVIOURS
- 8.15. HYPERBARIC OXYGEN THERAPY FOR AUTISTIC BEHAVIOURS
- 9. SUMMARY OF RECOMMENDATIONS
- 9.1. GENERAL PRINCIPLES OF CARE
- 9.2. IDENTIFICATION AND ASSESSMENT
- 9.3. INTERVENTIONS FOR AUTISM
- 9.4. INTERVENTIONS FOR CHALLENGING BEHAVIOUR
- 9.5. INTERVENTIONS FOR COEXISTING MENTAL DISORDERS
- 9.6. ASSESSMENT AND INTERVENTIONS FOR FAMILIES, PARTNERS AND CARERS
- 9.7. ORGANISATION AND DELIVERY OF CARE
- 9.8. RESIDENTIAL CARE
- 9.9. RESEARCH RECOMMENDATIONS
- APPENDICES
- APPENDIX 1. SCOPE FOR THE DEVELOPMENT OF THE CLINICAL GUIDELINE
- APPENDIX 2. DECLARATIONS OF INTERESTS BY GUIDELINE DEVELOPMENT GROUP MEMBERS
- APPENDIX 3. SPECIAL ADVISORS TO THE GUIDELINE DEVELOPMENT GROUP
- APPENDIX 4. STAKEHOLDERS WHO RESPONDED TO EARLY REQUESTS FOR EVIDENCE
- APPENDIX 5. STAKEHOLDERS AND EXPERTS WHO SUBMITTED COMMENTS IN RESPONSE TO THE CONSULTATION DRAFT OF THE GUIDELINE
- APPENDIX 6. RESEARCHERS CONTACTED TO REQUEST INFORMATION ABOUT UNPUBLISHED OR SOON-TO-BE PUBLISHED STUDIES
- APPENDIX 7. ANALYTIC FRAMEWORK AND REVIEW QUESTIONS
- APPENDIX 8. REVIEW PROTOCOLS
- APPENDIX 9. SEARCH STRATEGIES FOR THE IDENTIFICATION OF CLINICAL STUDIES
- APPENDIX 10. QUALITY CHECKLIST TEMPLATES FOR CLINICAL STUDIES AND REVIEWS
- APPENDIX 11. SEARCH STRATEGIES FOR THE IDENTIFICATION OF HEALTH ECONOMIC EVIDENCE
- APPENDIX 12. METHODOLOGY CHECKLIST TEMPLATE FOR ECONOMIC STUDIES
- APPENDIX 13. RESEARCH RECOMMENDATIONS
- Appendix 14. Clinical evidence – study characteristics tables
- APPENDIX 15. CLINICAL EVIDENCE – FOREST PLOTS
- APPENDIX 16. COMPLETED METHODOLOGY CHECKLISTS
- APPENDIX 17. HEALTH ECONOMIC EVIDENCE – COMPLETED METHODOLOGY CHECKLISTS
- APPENDIX 18. HEALTH ECONOMIC EVIDENCE – EVIDENCE TABLES OF PUBLISHED STUDIES
- APPENDIX 19. GRADE EVIDENCE PROFILES
- REFERENCES
- ABBREVIATIONS
The views presented in this book do not necessarily reflect those of the British Psychological Society, and the publishers are not responsible for any error of omission or fact. The British Psychological Society is a registered charity (no. 229642).
- Autism in adults: Evidence Update May 2014: A summary of selected new evidence relevant to NICE clinical guideline 142 'Autism: recognition, referral, diagnosis and management of adults on the autism spectrum' (2012)
- Surveillance report 2016 - Autism spectrum disorder in adults (2012) NICE guideline CG142
- Review Autism spectrum disorder in under 19s: support and management[ 2021]Review Autism spectrum disorder in under 19s: support and management. 2021 Jun 14
- Review Autism spectrum disorder in adults: diagnosis and management[ 2021]Review Autism spectrum disorder in adults: diagnosis and management. 2021 Jun 14
- Review Antisocial Behaviour and Conduct Disorders in Children and Young People: Recognition, Intervention and Management[ 2013]Review Antisocial Behaviour and Conduct Disorders in Children and Young People: Recognition, Intervention and ManagementNational Collaborating Centre for Mental Health (UK), Social Care Institute for Excellence (UK). 2013
- Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.[Med J Aust. 2019]Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Hickie IB, Scott EM, Cross SP, Iorfino F, Davenport TA, Guastella AJ, Naismith SL, Carpenter JS, Rohleder C, Crouse JJ, et al. Med J Aust. 2019 Nov; 211 Suppl 9:S3-S46.
- Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.[JBI Libr Syst Rev. 2009]Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.Rees S, Williams A. JBI Libr Syst Rev. 2009; 7(13):492-582.